Deadly DAaRTS destroy cancer cells via a tumor microenvironment–mediated trigger
James V. McCann,1 Jamie L. Null,2 and Andrew C. Dudley2,3
1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
2Department of Microbiology, Immunology, and Cancer Biology, and
3Emily Couric Cancer Center, The University of Virginia, Charlottesville, Virginia, USA.
Address correspondence to: Andrew C. Dudley, Department of Microbiology, Immunology, and Cancer Biology, The University of Virginia, Charlottesville, Virginia 22908, USA. Phone: 434.924.7766; Email: acd2g@virginia.edu.
Find articles by McCann, J. in: JCI | PubMed | Google Scholar
1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
2Department of Microbiology, Immunology, and Cancer Biology, and
3Emily Couric Cancer Center, The University of Virginia, Charlottesville, Virginia, USA.
Address correspondence to: Andrew C. Dudley, Department of Microbiology, Immunology, and Cancer Biology, The University of Virginia, Charlottesville, Virginia 22908, USA. Phone: 434.924.7766; Email: acd2g@virginia.edu.
Find articles by Null, J. in: JCI | PubMed | Google Scholar
1Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
2Department of Microbiology, Immunology, and Cancer Biology, and
3Emily Couric Cancer Center, The University of Virginia, Charlottesville, Virginia, USA.
Address correspondence to: Andrew C. Dudley, Department of Microbiology, Immunology, and Cancer Biology, The University of Virginia, Charlottesville, Virginia 22908, USA. Phone: 434.924.7766; Email: acd2g@virginia.edu.
Find articles by Dudley, A. in: JCI | PubMed | Google Scholar
First published June 4, 2018 - More info
J Clin Invest. 2018;128(7):2750–2753. https://doi.org/10.1172/JCI121527.
Copyright © 2018, American Society for Clinical Investigation
Stromal cells within the tumor microenvironment play a supportive role in tumor growth, progression, and treatment resistance; therefore, these nonmalignant cells are potential therapeutic targets. In this issue of the JCI, Szot et al. devised a strategy to exploit the cell-surface marker TEM8 (also known as ANTXR1), which is expressed by cancer-associated stromal cells, as a zip code to deliver an antibody-drug conjugate (ADC) linked to the potent cancer-killing drug monomethyl auristatin E (MMAE). In preclinical tumor and experimental metastasis models of multiple cancer types, TEM8-ADC targeted TEM8-expressing cancer-associated stromal cells, which processed and liberated membrane-permeable MMAE and released this drug via the P-glycoprotein (P-gp) drug transporter. Released MMAE killed cancer cells through a bystander mechanism that did minimal damage to the stromal cells themselves. P-gp–expressing tumor cells displayed MMAE resistance, suggesting that P-gp expression status may identify patients who might benefit the most from TEM8-ADC. This strategy, termed DAaRTS (drug activation and release through stroma), represents an elegant example of how selective expression of a cell-surface molecule on cancer-associated stroma can be exploited to facilitate drug delivery and shrink solid tumors.
- Purchase this article
- $10
- Purchasing this article will give you full access for the calendar year.
- Purchase Site Pass
- $25
- This will give you access to every article on the site for 24 hours.
- Online subscription
- $95
- Individual online subscriptions give you full online access for the calendar year.
- Print subscription
- $795
- Individual print subscriptions give you the print journal and full online access for the year.
- JCI This Month subscription
- $125
- JCI This Month is a 16- to 20-page overview of the articles published each month
- Subscribing to JCI This Month also gives subscribers full online access for the calendar year.
- *Price outside U.S. and Canada: $225.
Copyright © 2018 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)